Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLong-Term Debt RepaymentsNon-Current ReceivablesPreferred Shares IssuedReceivables RefundsShares IssuedShares Outstanding
Ratios

Ascendis Pharma A (ASND) Depreciation & Amortization (IS): 2014-2019

Historic Depreciation & Amortization (IS) for Ascendis Pharma A (ASND) over the last 4 years, with Jun 2019 value amounting to $1.7 million.

  • Ascendis Pharma A's Depreciation & Amortization (IS) was N/A to $1.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $10.8 million for FY2020, which is 161171.93% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Depreciation & Amortization (IS) of $1.7 million as of Q2 2019, which was up 14.72% from $1.5 million recorded in Q1 2019.
  • Ascendis Pharma A's Depreciation & Amortization (IS)'s 5-year high stood at $1.7 million during Q2 2019, with a 5-year trough of $138,969 in Q1 2015.
  • Moreover, its 3-year median value for Depreciation & Amortization (IS) was $252,063 (2017), whereas its average is $568,780.
  • As far as peak fluctuations go, Ascendis Pharma A's Depreciation & Amortization (IS) fell by 14.78% in 2015, and later rose by 29.10% in 2016.
  • Ascendis Pharma A's Depreciation & Amortization (IS) (Quarterly) stood at $167,706 in 2015, then increased by 11.38% to $186,792 in 2016, then grew by 24.18% to $231,954 in 2017, then rose by 22.53% to $284,208 in 2018, then reached $1.7 million in 2019.
  • Its last three reported values are $1.7 million in Q2 2019, $1.5 million for Q1 2019, and $284,208 during Q4 2018.